Feasibility of an adapted schedule of carboplatin plus paclitaxel in elderly women with advanced ovarian cancer: A retrospective cohort.

Benjamin Nicaise,Soraya Mebarki,Mathilde Gisselbrecht,Elisabeth Ashton,Henri Azaïs,Meriem Koual,Anne-Sophie Bats,Laure Fournier,Marie-Aude Le Frère-Belda,J. Medioni,Elena Paillaud,Stéphane Oudard,Nicolas Delanoy

Feasibility of an adapted schedule of carboplatin plus paclitaxel in elderly women with advanced ovarian cancer: A retrospective cohort.

2021

Benjamin Nicaise
Soraya Mebarki
Mathilde Gisselbrecht
Elisabeth Ashton
Henri Azaïs
Meriem Koual
Anne-Sophie Bats
Laure Fournier
Marie-Aude Le Frère-Belda
J. Medioni
Elena Paillaud
Stéphane Oudard
Nicolas Delanoy

5546Background: The EWOC-1 trial compared Carboplatin monotherapy (C mono) to two different Carboplatin + Paclitaxel (CP) regimens (weekly or 3-weekly) in vulnerable elderly patients treated for ad...

Keywords:

Schedule
advanced ovarian cancer
Retrospective cohort study
Oncology
Internal medicine
Medicine
Paclitaxel
Carboplatin

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations